(Q80350650)

English

Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial

scientific article published on 01 June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

randomized controlled trial

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

Wolfgang H. Oertel

5

object named as

Wolfgang H Oertel

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Werner H Poewe

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Olivier Rascol

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Niall Quinn

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Eduardo Tolosa

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Emilia Martignoni

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Markus Rupp

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Babak Boroojerdi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

SP 515 Investigators

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 June 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lancet Neurology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

513-520

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Levodopa in the treatment of Parkinson's disease: current controversies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose L-dopa therapy in Parkinson's disease: a 6-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Entacapone in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolcapone: a review of its use in the management of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous dopamine-receptor stimulation in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel dopamine agonist for the transdermal treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A promising new technology for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of rotigotine monotherapy in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical studies with transdermal rotigotine in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug adherence in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Medicine-taking behavior: implications of suboptimal compliance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Transdermal delivery of dopaminergic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970108-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(07)70108-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17509486%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80350650&oldid=1796428989"